Knight Therapeutics Inc. (GUD.TO)
CAD 5.21
(-0.19%)
CAD 5.21
(-0.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 28.49 Million | 40.48 Million | 44.61 Million | -12.2 Million | 4.59 Million | -5.73 Million |
| Net Income | -16.83 Million | -29.89 Million | 15.67 Million | 31.76 Million | 18.03 Million | 24.07 Million |
| Depreciation & Amortization | 50.39 Million | 62.62 Million | 47.91 Million | 32.07 Million | 4.27 Million | 1.93 Million |
| Deferred income taxes | -9.12 Million | -17.12 Million | -7.63 Million | -2.01 Million | 913 Thousand | 1.85 Million |
| Stock-based compensation | 2.32 Million | 1.88 Million | 3.04 Million | 1.95 Million | 2.13 Million | 2.17 Million |
| Change in working capital | -28.01 Million | -9.98 Million | 627 Thousand | -21.6 Million | -12.19 Million | -23.33 Million |
| Other non-cash items | 29.74 Million | 32.97 Million | -15 Million | -54.37 Million | -8.55 Million | -12.43 Million |
| Investing Cash Flow | 26.9 Million | -63.07 Million | -105.27 Million | 101.35 Million | -11.86 Million | -252.31 Million |
| Investments in PPE | -9.95 Million | -25.81 Million | -224.18 Million | -20.66 Million | -2.94 Million | -3.87 Million |
| Acquisitions | 1.92 Million | - | -220.35 Million | -170.85 Million | -172.3 Million | 3.28 Million |
| Investment purchases | -334.16 Million | -185.47 Million | -64.32 Million | -53.94 Million | -247.66 Million | -586.48 Million |
| Sales/Maturities of investments | 345.46 Million | 150.54 Million | 180.54 Million | 269.37 Million | 422.56 Million | 302.31 Million |
| Other Investing Activities | 23.63 Million | -2.33 Million | 223.03 Million | 77.43 Million | -11.5 Million | 32.44 Million |
| Financing Cash Flow | -71.12 Million | 1.76 Million | -78.31 Million | -29.23 Million | -62.79 Million | 290 Thousand |
| Debt repayment | -15.17 Million | -20.29 Million | -23.61 Million | -17.85 Million | -8.61 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -53.47 Million | -30.06 Million | -64.41 Million | -36.78 Million | -54.83 Million | - |
| Common Stock Issuance | 380 Thousand | 340 Thousand | 297 Thousand | 826 Thousand | 230 Thousand | 290 Thousand |
| Other Financing Activities | -2.85 Million | 52.12 Million | 9.72 Million | 25.4 Million | 655 Thousand | 290 Thousand |
| Accounts receivables | 5.57 Million | -26.41 Million | 8.59 Million | 20.1 Million | -10.4 Million | -2.58 Million |
| Accounts payables | -21.62 Million | 30.6 Million | 11.45 Million | -46.85 Million | 10.68 Million | 1.07 Million |
| Inventory | 698 Thousand | -11.42 Million | -17.18 Million | 9.7 Million | 8.14 Million | 88 Thousand |
| Other working capital | -12.65 Million | -2.74 Million | -2.23 Million | -4.56 Million | -20.62 Million | -21.92 Million |
| Cash at beginning of period | 71.67 Million | 85.96 Million | 229.59 Million | 174.26 Million | 244.78 Million | 496.46 Million |
| Cash at end of period | 58.76 Million | 71.67 Million | 85.96 Million | 229.59 Million | 174.26 Million | 244.78 Million |
| Capital Expenditure | -9.95 Million | -25.81 Million | -224.18 Million | -20.66 Million | -2.94 Million | -3.87 Million |
| Effect of forex changes on cash | 2.8 Million | 6.55 Million | -4.65 Million | -4.59 Million | -458 Thousand | 6.08 Million |
| Net cash flow / Change in cash | -12.91 Million | -14.28 Million | -143.62 Million | 55.32 Million | -70.51 Million | -251.67 Million |
| Free Cash Flow | 18.53 Million | 14.66 Million | -179.56 Million | -32.87 Million | 1.64 Million | -9.61 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.94 Million | -4.54 Million | -24.32 Million | -16.83 Million | 9.58 Million | 1.84 Million |
| Depreciation & Amortization | 13.16 Million | 12.58 Million | 11.45 Million | 50.39 Million | 13.69 Million | 12.15 Million |
| Deferred income taxes | 1.41 Million | -4.26 Million | -2.54 Million | -9.12 Million | -1.8 Million | -1.66 Million |
| Stock-based compensation | 1.05 Million | 510 Thousand | 367 Thousand | 2.32 Million | 349 Thousand | 828 Thousand |
| Change in working capital | -11.93 Million | 15.5 Million | 5.29 Million | -28.01 Million | -7.23 Million | -11.14 Million |
| Other non-cash items | 36.8 Million | 21.59 Million | 19.42 Million | 29.74 Million | 568 Thousand | -3.5 Million |
| Investing Cash Flow | 9.55 Million | -24.94 Million | -3.5 Million | 26.9 Million | 35.75 Million | 4.2 Million |
| Investments in PPE | -17.42 Million | -10.99 Million | -1.72 Million | -9.95 Million | -287 Thousand | -158 Thousand |
| Acquisitions | 3000.00 | 58 Thousand | 1.92 Million | 1.92 Million | -60 Thousand | - |
| Investment purchases | -42.69 Million | -36.42 Million | -95.31 Million | -334.16 Million | -53.12 Million | -76.48 Million |
| Sales/Maturities of investments | 69.67 Million | 22.31 Million | 80.74 Million | 345.46 Million | 81.75 Million | 75.48 Million |
| Other Investing Activities | 12.44 Million | 97 Thousand | 10.86 Million | 23.63 Million | 7.47 Million | 5.35 Million |
| Financing Cash Flow | -8.06 Million | -1.99 Million | -25.81 Million | -71.12 Million | -11.23 Million | -22.09 Million |
| Debt repayment | -6.18 Million | -1.18 Million | -6.12 Million | -15.17 Million | -3.35 Million | -5.88 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.24 Million | - | -19.08 Million | -53.47 Million | -9.83 Million | -13.95 Million |
| Common Stock Issuance | 340 Thousand | 74 Thousand | 95 Thousand | 380 Thousand | 88 Thousand | 105 Thousand |
| Other Financing Activities | -2.95 Million | -831 Thousand | -705 Thousand | -2.85 Million | 1.94 Million | -2.26 Million |
| Accounts receivables | 998 Thousand | 1.28 Million | -1.8 Million | 5.57 Million | 17.11 Million | 3.04 Million |
| Accounts payables | -8.69 Million | 9.37 Million | -590 Thousand | -21.62 Million | -6.69 Million | -17.02 Million |
| Inventory | -5.65 Million | 4.19 Million | 18.35 Million | 698 Thousand | -12.95 Million | -2.07 Million |
| Other working capital | 1.42 Million | 657 Thousand | -10.66 Million | -12.65 Million | -4.7 Million | 4.91 Million |
| Cash at beginning of period | 62.83 Million | 58.76 Million | 77.41 Million | 71.67 Million | 37.84 Million | 56.21 Million |
| Cash at end of period | 60.8 Million | 62.83 Million | 58.76 Million | 58.76 Million | 77.41 Million | 37.84 Million |
| Capital Expenditure | -17.42 Million | -10.99 Million | -1.72 Million | -9.95 Million | -287 Thousand | -158 Thousand |
| Effect of forex changes on cash | -1.33 Million | 456 Thousand | 999 Thousand | 2.8 Million | -109 Thousand | 1 Million |
| Net cash flow / Change in cash | -2.02 Million | 4.07 Million | -18.65 Million | -12.91 Million | 39.57 Million | -18.37 Million |
| Free Cash Flow | -19.6 Million | 19.56 Million | 7.94 Million | 18.53 Million | 14.87 Million | -1.64 Million |
SWIN
HFBK
000833
YEWTF
001213
NTOIY